.
MergerLinks Header Logo

New Deal


Announced

Everlife-backed CPC Diagnostics completed the acquisition of the POCT division of Weldon Biotech and SM Biotech.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Domestic

Single Bidder

Majority

Completed

biomarkers

Biotechnology

Private

India

Friendly

Acquisition

Synopsis

Edit

Everlife-backed CPC Diagnostics, a provider of clinical diagnostic products and services, completed the acquisition of the POCT division of Weldon Biotech, a manufacturer and distributor of in vitro diagnostic products, and SM Biotech, a unit of mushroom machinery manufacturing. Financial terms were not disclosed.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US